NEUROCRINE BIOSCIENCES INC Quarterly Operating Income (Loss) in USD from Q2 2010 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Neurocrine Biosciences Inc quarterly/annual Operating Income (Loss) history and growth rate from Q2 2010 to Q2 2024.
  • Neurocrine Biosciences Inc Operating Income (Loss) for the quarter ending June 30, 2024 was $145M, a 97.6% increase year-over-year.
  • Neurocrine Biosciences Inc Operating Income (Loss) for the twelve months ending June 30, 2024 was $536M, a 256% increase year-over-year.
  • Neurocrine Biosciences Inc annual Operating Income (Loss) for 2023 was $251M, a 0.76% increase from 2022.
  • Neurocrine Biosciences Inc annual Operating Income (Loss) for 2022 was $249M, a 143% increase from 2021.
  • Neurocrine Biosciences Inc annual Operating Income (Loss) for 2021 was $103M, a 37.1% decline from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 $536M $145M +$71.8M +97.6% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-01
Q1 2024 $464M $99.3M +$214M Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-01
Q4 2023 $251M $150M +$46.9M +45.4% Oct 1, 2023 Dec 31, 2023 10-K 2024-02-09
Q3 2023 $204M $141M +$53.4M +60.8% Jul 1, 2023 Sep 30, 2023 10-Q 2023-10-31
Q2 2023 $151M $73.6M +$18.9M +34.6% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-01
Q1 2023 $132M -$114M -$117M -3784% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-01
Q4 2022 $249M $103M +$140M Oct 1, 2022 Dec 31, 2022 10-K 2024-02-09
Q3 2022 $109M $87.8M +$43.3M +97.3% Jul 1, 2022 Sep 30, 2022 10-Q 2023-10-31
Q2 2022 $66M $54.7M -$8.1M -12.9% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-01
Q1 2022 $74.1M $3.1M -$28.4M -90.2% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-03
Q4 2021 $103M -$36.3M -$108M -151% Oct 1, 2021 Dec 31, 2021 10-K 2024-02-09
Q3 2021 $211M $44.5M +$88.8M Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-01
Q2 2021 $122M $62.8M -$13.8M -18% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-04
Q1 2021 $136M $31.5M -$27.4M -46.5% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-04
Q4 2020 $163M $71.8M +$23M +47.1% Oct 1, 2020 Dec 31, 2020 10-K 2023-02-09
Q3 2020 $140M -$44.3M -$134M -149% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-01
Q2 2020 $274M $76.6M +$42.2M +123% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-03
Q1 2020 $232M $58.9M +$160M Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-05
Q4 2019 $72.3M $48.8M +$27M +124% Oct 1, 2019 Dec 31, 2019 10-K 2022-02-11
Q3 2019 $45.3M $90.1M +$35.8M +65.9% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-09
Q2 2019 $9.5M $34.4M +$36.3M Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-03
Q1 2019 -$26.8M -$101M -$63.6M -170% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-06
Q4 2018 $36.8M $21.8M +$9.94M +84% Oct 1, 2018 Dec 31, 2018 10-K 2021-02-05
Q3 2018 $26.9M $54.3M +$60.3M Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-04
Q2 2018 -$33.5M -$1.85M +$55.4M +96.8% Apr 1, 2018 Jun 30, 2018 10-Q 2019-07-29
Q1 2018 -$88.9M -$37.4M +$42.5M +53.2% Jan 1, 2018 Mar 31, 2018 10-Q 2019-04-29
Q4 2017 -$131M $11.8M +$58.1M Oct 1, 2017 Dec 31, 2017 10-K 2020-02-07
Q3 2017 -$189M -$6M +$32.4M +84.4% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-05
Q2 2017 -$222M -$57.3M -$15.4M -36.9% Apr 1, 2017 Jun 30, 2017 10-Q 2018-07-31
Q1 2017 -$206M -$79.9M -$59.1M -283% Jan 1, 2017 Mar 31, 2017 10-Q 2018-04-30
Q4 2016 -$147M -$46.3M -$15.5M -50.4% Oct 1, 2016 Dec 31, 2016 10-K 2019-02-08
Q3 2016 -$132M -$38.4M -$2.59M -7.23% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-01
Q2 2016 -$129M -$41.8M -$16.5M -65.2% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-03
Q1 2016 -$113M -$20.9M -$18.6M -812% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-09
Q4 2015 -$94.2M -$30.7M -$10.3M -50.2% Oct 1, 2015 Dec 31, 2015 10-K 2018-02-13
Q3 2015 -$83.9M -$35.8M -$19M -113% Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-02
Q2 2015 -$64.9M -$25.3M -$11M -76.3% Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-03
Q1 2015 -$54M -$2.29M +$10.4M +82% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-05
Q4 2014 -$64.4M -$20.5M -$8.94M -77.5% Oct 1, 2014 Dec 31, 2014 10-K 2017-02-14
Q3 2014 -$55.5M -$16.9M -$4.85M -40.4% Jul 1, 2014 Sep 30, 2014 10-Q 2015-10-29
Q2 2014 -$50.6M -$14.4M -$1.19M -9.07% Apr 1, 2014 Jun 30, 2014 10-Q 2015-07-29
Q1 2014 -$49.4M -$12.7M +$250K +1.93% Jan 1, 2014 Mar 31, 2014 10-Q 2015-04-30
Q4 2013 -$49.7M -$11.5M -$20.1M -234% Oct 1, 2013 Dec 31, 2013 10-K 2016-02-11
Q3 2013 -$29.6M -$12M -$8.04M -203% Jul 1, 2013 Sep 30, 2013 10-Q 2014-11-04
Q2 2013 -$21.5M -$13.2M -$11.8M -854% Apr 1, 2013 Jun 30, 2013 10-Q 2014-08-06
Q1 2013 -$9.74M -$13M -$11.2M -624% Jan 1, 2013 Mar 31, 2013 10-Q 2014-05-01
Q4 2012 $1.45M $8.58M +$8.14M +1820% Oct 1, 2012 Dec 31, 2012 10-K 2015-02-09
Q3 2012 -$6.69M -$3.96M -$34.4M -113% Jul 1, 2012 Sep 30, 2012 10-Q 2013-10-29
Q2 2012 $27.7M -$1.38M -$2.48M -226% Apr 1, 2012 Jun 30, 2012 10-Q 2013-07-26
Q1 2012 $30.2M -$1.79M -$3.73M -192% Jan 1, 2012 Mar 31, 2012 10-Q 2013-05-02
Q4 2011 $33.9M $447K Oct 1, 2011 Dec 31, 2011 10-K 2014-02-11
Q3 2011 $30.4M +$28M +1134% Jul 1, 2011 Sep 30, 2011 10-Q 2012-10-31
Q2 2011 $1.1M +$6.99M Apr 1, 2011 Jun 30, 2011 10-Q 2012-07-31
Q1 2011 $1.94M Jan 1, 2011 Mar 31, 2011 10-Q 2012-05-02
Q3 2010 $2.47M Jul 1, 2010 Sep 30, 2010 10-Q 2011-10-31
Q2 2010 -$5.89M Apr 1, 2010 Jun 30, 2010 10-Q 2011-07-29
* An asterisk sign (*) next to the value indicates that the value is likely invalid.